Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care
Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was us...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Gnanasan, Shubashini [verfasserIn] Ting, Kang Nee [verfasserIn] Wong, Kok Thong [verfasserIn] Mohd Ali, Salmiah [verfasserIn] Muttalif, Abdul Razak [verfasserIn] Anderson, Claire [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2011 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Pharmacy world & science - Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979, 33(2011), 1 vom: 14. Jan., Seite 44-52 |
|---|---|
| Übergeordnetes Werk: |
volume:33 ; year:2011 ; number:1 ; day:14 ; month:01 ; pages:44-52 |
| Links: |
|---|
| DOI / URN: |
10.1007/s11096-010-9452-3 |
|---|
| Katalog-ID: |
SPR016599829 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR016599829 | ||
| 003 | DE-627 | ||
| 005 | 20230519114858.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201006s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11096-010-9452-3 |2 doi | |
| 035 | |a (DE-627)SPR016599829 | ||
| 035 | |a (SPR)s11096-010-9452-3-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.40 |2 bkl | ||
| 100 | 1 | |a Gnanasan, Shubashini |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| 264 | 1 | |c 2011 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. | ||
| 650 | 4 | |a Action research |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Diabetes mellitus |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Individualised care |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Malaysia |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pharmaceutical care |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Pharmacist |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Tuberculosis |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Ting, Kang Nee |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Kok Thong |e verfasserin |4 aut | |
| 700 | 1 | |a Mohd Ali, Salmiah |e verfasserin |4 aut | |
| 700 | 1 | |a Muttalif, Abdul Razak |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Claire |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacy world & science |d Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 |g 33(2011), 1 vom: 14. Jan., Seite 44-52 |w (DE-627)320474054 |w (DE-600)2008911-9 |x 1573-739X |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2011 |g number:1 |g day:14 |g month:01 |g pages:44-52 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11096-010-9452-3 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-ASE | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_23 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_31 | ||
| 912 | |a GBV_ILN_32 | ||
| 912 | |a GBV_ILN_39 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a GBV_ILN_60 | ||
| 912 | |a GBV_ILN_62 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_73 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a GBV_ILN_90 | ||
| 912 | |a GBV_ILN_95 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_110 | ||
| 912 | |a GBV_ILN_120 | ||
| 912 | |a GBV_ILN_138 | ||
| 912 | |a GBV_ILN_152 | ||
| 912 | |a GBV_ILN_161 | ||
| 912 | |a GBV_ILN_171 | ||
| 912 | |a GBV_ILN_187 | ||
| 912 | |a GBV_ILN_224 | ||
| 912 | |a GBV_ILN_250 | ||
| 912 | |a GBV_ILN_281 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_293 | ||
| 912 | |a GBV_ILN_370 | ||
| 912 | |a GBV_ILN_602 | ||
| 912 | |a GBV_ILN_702 | ||
| 936 | b | k | |a 44.40 |q ASE |
| 951 | |a AR | ||
| 952 | |d 33 |j 2011 |e 1 |b 14 |c 01 |h 44-52 | ||
| author_variant |
s g sg k n t kn knt k t w kt ktw a s m as asm a r m ar arm c a ca |
|---|---|
| matchkey_str |
article:1573739X:2011----::ovrecotbruoiadibtseltsieoniiul |
| hierarchy_sort_str |
2011 |
| bklnumber |
44.40 |
| publishDate |
2011 |
| allfields |
10.1007/s11096-010-9452-3 doi (DE-627)SPR016599829 (SPR)s11096-010-9452-3-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Gnanasan, Shubashini verfasserin aut Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 Ting, Kang Nee verfasserin aut Wong, Kok Thong verfasserin aut Mohd Ali, Salmiah verfasserin aut Muttalif, Abdul Razak verfasserin aut Anderson, Claire verfasserin aut Enthalten in Pharmacy world & science Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 33(2011), 1 vom: 14. Jan., Seite 44-52 (DE-627)320474054 (DE-600)2008911-9 1573-739X nnns volume:33 year:2011 number:1 day:14 month:01 pages:44-52 https://dx.doi.org/10.1007/s11096-010-9452-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 44.40 ASE AR 33 2011 1 14 01 44-52 |
| spelling |
10.1007/s11096-010-9452-3 doi (DE-627)SPR016599829 (SPR)s11096-010-9452-3-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Gnanasan, Shubashini verfasserin aut Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 Ting, Kang Nee verfasserin aut Wong, Kok Thong verfasserin aut Mohd Ali, Salmiah verfasserin aut Muttalif, Abdul Razak verfasserin aut Anderson, Claire verfasserin aut Enthalten in Pharmacy world & science Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 33(2011), 1 vom: 14. Jan., Seite 44-52 (DE-627)320474054 (DE-600)2008911-9 1573-739X nnns volume:33 year:2011 number:1 day:14 month:01 pages:44-52 https://dx.doi.org/10.1007/s11096-010-9452-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 44.40 ASE AR 33 2011 1 14 01 44-52 |
| allfields_unstemmed |
10.1007/s11096-010-9452-3 doi (DE-627)SPR016599829 (SPR)s11096-010-9452-3-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Gnanasan, Shubashini verfasserin aut Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 Ting, Kang Nee verfasserin aut Wong, Kok Thong verfasserin aut Mohd Ali, Salmiah verfasserin aut Muttalif, Abdul Razak verfasserin aut Anderson, Claire verfasserin aut Enthalten in Pharmacy world & science Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 33(2011), 1 vom: 14. Jan., Seite 44-52 (DE-627)320474054 (DE-600)2008911-9 1573-739X nnns volume:33 year:2011 number:1 day:14 month:01 pages:44-52 https://dx.doi.org/10.1007/s11096-010-9452-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 44.40 ASE AR 33 2011 1 14 01 44-52 |
| allfieldsGer |
10.1007/s11096-010-9452-3 doi (DE-627)SPR016599829 (SPR)s11096-010-9452-3-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Gnanasan, Shubashini verfasserin aut Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 Ting, Kang Nee verfasserin aut Wong, Kok Thong verfasserin aut Mohd Ali, Salmiah verfasserin aut Muttalif, Abdul Razak verfasserin aut Anderson, Claire verfasserin aut Enthalten in Pharmacy world & science Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 33(2011), 1 vom: 14. Jan., Seite 44-52 (DE-627)320474054 (DE-600)2008911-9 1573-739X nnns volume:33 year:2011 number:1 day:14 month:01 pages:44-52 https://dx.doi.org/10.1007/s11096-010-9452-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 44.40 ASE AR 33 2011 1 14 01 44-52 |
| allfieldsSound |
10.1007/s11096-010-9452-3 doi (DE-627)SPR016599829 (SPR)s11096-010-9452-3-e DE-627 ger DE-627 rakwb eng 610 ASE 44.40 bkl Gnanasan, Shubashini verfasserin aut Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care 2011 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 Ting, Kang Nee verfasserin aut Wong, Kok Thong verfasserin aut Mohd Ali, Salmiah verfasserin aut Muttalif, Abdul Razak verfasserin aut Anderson, Claire verfasserin aut Enthalten in Pharmacy world & science Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979 33(2011), 1 vom: 14. Jan., Seite 44-52 (DE-627)320474054 (DE-600)2008911-9 1573-739X nnns volume:33 year:2011 number:1 day:14 month:01 pages:44-52 https://dx.doi.org/10.1007/s11096-010-9452-3 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 44.40 ASE AR 33 2011 1 14 01 44-52 |
| language |
English |
| source |
Enthalten in Pharmacy world & science 33(2011), 1 vom: 14. Jan., Seite 44-52 volume:33 year:2011 number:1 day:14 month:01 pages:44-52 |
| sourceStr |
Enthalten in Pharmacy world & science 33(2011), 1 vom: 14. Jan., Seite 44-52 volume:33 year:2011 number:1 day:14 month:01 pages:44-52 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Action research Diabetes mellitus Individualised care Malaysia Pharmaceutical care Pharmacist Tuberculosis |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Pharmacy world & science |
| authorswithroles_txt_mv |
Gnanasan, Shubashini @@aut@@ Ting, Kang Nee @@aut@@ Wong, Kok Thong @@aut@@ Mohd Ali, Salmiah @@aut@@ Muttalif, Abdul Razak @@aut@@ Anderson, Claire @@aut@@ |
| publishDateDaySort_date |
2011-01-14T00:00:00Z |
| hierarchy_top_id |
320474054 |
| dewey-sort |
3610 |
| id |
SPR016599829 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR016599829</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519114858.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2011 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11096-010-9452-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR016599829</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11096-010-9452-3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gnanasan, Shubashini</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Action research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Individualised care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malaysia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacist</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ting, Kang Nee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wong, Kok Thong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohd Ali, Salmiah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muttalif, Abdul Razak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anderson, Claire</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Pharmacy world & science</subfield><subfield code="d">Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979</subfield><subfield code="g">33(2011), 1 vom: 14. Jan., Seite 44-52</subfield><subfield code="w">(DE-627)320474054</subfield><subfield code="w">(DE-600)2008911-9</subfield><subfield code="x">1573-739X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:1</subfield><subfield code="g">day:14</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:44-52</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11096-010-9452-3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_138</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="j">2011</subfield><subfield code="e">1</subfield><subfield code="b">14</subfield><subfield code="c">01</subfield><subfield code="h">44-52</subfield></datafield></record></collection>
|
| author |
Gnanasan, Shubashini |
| spellingShingle |
Gnanasan, Shubashini ddc 610 bkl 44.40 misc Action research misc Diabetes mellitus misc Individualised care misc Malaysia misc Pharmaceutical care misc Pharmacist misc Tuberculosis Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| authorStr |
Gnanasan, Shubashini |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)320474054 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut aut aut aut aut aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1573-739X |
| topic_title |
610 ASE 44.40 bkl Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care Action research (dpeaa)DE-He213 Diabetes mellitus (dpeaa)DE-He213 Individualised care (dpeaa)DE-He213 Malaysia (dpeaa)DE-He213 Pharmaceutical care (dpeaa)DE-He213 Pharmacist (dpeaa)DE-He213 Tuberculosis (dpeaa)DE-He213 |
| topic |
ddc 610 bkl 44.40 misc Action research misc Diabetes mellitus misc Individualised care misc Malaysia misc Pharmaceutical care misc Pharmacist misc Tuberculosis |
| topic_unstemmed |
ddc 610 bkl 44.40 misc Action research misc Diabetes mellitus misc Individualised care misc Malaysia misc Pharmaceutical care misc Pharmacist misc Tuberculosis |
| topic_browse |
ddc 610 bkl 44.40 misc Action research misc Diabetes mellitus misc Individualised care misc Malaysia misc Pharmaceutical care misc Pharmacist misc Tuberculosis |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Pharmacy world & science |
| hierarchy_parent_id |
320474054 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Pharmacy world & science |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)320474054 (DE-600)2008911-9 |
| title |
Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| ctrlnum |
(DE-627)SPR016599829 (SPR)s11096-010-9452-3-e |
| title_full |
Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| author_sort |
Gnanasan, Shubashini |
| journal |
Pharmacy world & science |
| journalStr |
Pharmacy world & science |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2011 |
| contenttype_str_mv |
txt |
| container_start_page |
44 |
| author_browse |
Gnanasan, Shubashini Ting, Kang Nee Wong, Kok Thong Mohd Ali, Salmiah Muttalif, Abdul Razak Anderson, Claire |
| container_volume |
33 |
| class |
610 ASE 44.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Gnanasan, Shubashini |
| doi_str_mv |
10.1007/s11096-010-9452-3 |
| dewey-full |
610 |
| author2-role |
verfasserin |
| title_sort |
convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| title_auth |
Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| abstract |
Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. |
| abstractGer |
Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. |
| abstract_unstemmed |
Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential. |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA SSG-OPC-PHA SSG-OPC-ASE GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_95 GBV_ILN_100 GBV_ILN_105 GBV_ILN_110 GBV_ILN_120 GBV_ILN_138 GBV_ILN_152 GBV_ILN_161 GBV_ILN_171 GBV_ILN_187 GBV_ILN_224 GBV_ILN_250 GBV_ILN_281 GBV_ILN_285 GBV_ILN_293 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 |
| container_issue |
1 |
| title_short |
Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care |
| url |
https://dx.doi.org/10.1007/s11096-010-9452-3 |
| remote_bool |
true |
| author2 |
Ting, Kang Nee Wong, Kok Thong Mohd Ali, Salmiah Muttalif, Abdul Razak Anderson, Claire |
| author2Str |
Ting, Kang Nee Wong, Kok Thong Mohd Ali, Salmiah Muttalif, Abdul Razak Anderson, Claire |
| ppnlink |
320474054 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.1007/s11096-010-9452-3 |
| up_date |
2024-07-03T23:57:56.769Z |
| _version_ |
1803604277877276673 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR016599829</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519114858.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201006s2011 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/s11096-010-9452-3</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR016599829</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)s11096-010-9452-3-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gnanasan, Shubashini</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Convergence of tuberculosis and diabetes mellitus: time to individualise pharmaceutical care</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2011</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Objective To assess the feasibility of providing a pharmacist-led pharmaceutical care service to patients with tuberculosis and diabetes mellitus. Setting The study was conducted at a tertiary hospital in the northern region of Peninsular Malaysia. Methods Action research methodology was used. Main outcome measure Pharmaceutical care issues. Results The prevalence of diabetes mellitus among newly diagnosed tuberculosis patients was 15% (53/352). Out of 53 patients identified, 35 participated in the study. Patients’ ages ranged between 29 and 73 years (mean of 52 ± 10 years). The male: female ratio was 1.7:1. Pharmaceutical care issues identified by pharmacists were nonadherence, uncontrolled diabetes mellitus, adverse drug reactions and individual patient’s medication related problems. Pharmacists were able to intervene and resolve some of the pharmaceutical care issues. Conclusion Pharmacists played an important role in integrating the provision of care for tuberculosis and diabetes mellitus by providing individualised pharmaceutical care management. There still remains a need to address logistic barriers that impinged on the ability to conduct the pharmaceutical care service to its full potential.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Action research</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Diabetes mellitus</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Individualised care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Malaysia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical care</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacist</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tuberculosis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ting, Kang Nee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wong, Kok Thong</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mohd Ali, Salmiah</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Muttalif, Abdul Razak</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Anderson, Claire</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Pharmacy world & science</subfield><subfield code="d">Dordrecht [u.a.] : Springer Science + Business Media B.V., 1979</subfield><subfield code="g">33(2011), 1 vom: 14. Jan., Seite 44-52</subfield><subfield code="w">(DE-627)320474054</subfield><subfield code="w">(DE-600)2008911-9</subfield><subfield code="x">1573-739X</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:1</subfield><subfield code="g">day:14</subfield><subfield code="g">month:01</subfield><subfield code="g">pages:44-52</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/s11096-010-9452-3</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-ASE</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_138</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_171</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_250</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_281</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.40</subfield><subfield code="q">ASE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="j">2011</subfield><subfield code="e">1</subfield><subfield code="b">14</subfield><subfield code="c">01</subfield><subfield code="h">44-52</subfield></datafield></record></collection>
|
| score |
7.400324 |